Publication | Open Access

Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2

Medicinal ChemistryDual InhibitorsMedicineImproved Anticancer EfficacyPharmacological AgentPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyPharmaceutical ChemistryDrug Discovery